KCNA3 and neoplasm: This radiolabeled ligand of Kv1.3 allowed the quantification of TEM cells infiltrating the tumor, which were increased in responding tumors, and raised the possibility that a similar strategy could be used to develop new biomarkers of response to immune checkpoint inhibitors.